The BODE index after lung volume reduction surgery correlates with survival

Chest

Volumn 129, Issue 4, 2006, Pages 873-878

  Imfeld, Stephan ^a   Block, Konrad E ^a   Weder, Walter ^a   Russi, Erich W ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

BODE index; COPD; Lung volume reduction surgery; Survival

Indexed keywords

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; BODE INDEX; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT TOOL; DYSPNEA; ENDOSCOPIC SURGERY; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG EMPHYSEMA; LUNG FUNCTION TEST; LUNG RESECTION; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RESPIRATORY TRACT PARAMETERS; RETROSPECTIVE STUDY; SPIROMETRY; STATISTICAL PARAMETERS; SURVIVAL RATE; THORACOSCOPY; WALKING;

EID: 33645961894     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.129.4.873     Document Type: Article

References (31)

1. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997; 349:1269-1276
2. Fletcher CM, Peto R, Tinker C, et al. The natural history of chronic bronchitis and emphysema. New York, NY: Oxford Press, 1976
3. Anthonisen N, Wright EC, Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 133:14-20
4. Burrows B. Predictors of loss of lung function and mortality in obstructive lung diseases. Eur Respir Rev 1991; 1:340-345
5. Report of the Medical Research Council Working Party. Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981; 1:681-685
6. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease. Ann Intern Med 1980; 93:391-398
7. Weitzenblum E, Hirth C, Ducolone A, et al. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax 1981; 36:752-758
8. Schols AM, Slangen J, Volovics L, et al. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157:1791-1797
9. Nishimura K, Izumi T, Tsukino M, et al. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121:1434-1440
10. Pinto-Plata VM, Cote C, Cabral H, et al. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 2004; 23:28-33
11. Oga T, Nishimura K, Tsukino M, et al. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med 2003; 167:544-549
12. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350:1005-1012
13. Anthonisen NR, Skeans MA, Wise RA, et al. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 2005; 142:233-239
14. Fan VS, Bryson CL, Curtis JR, et al. Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: time-dependent analysis. Am J Respir Crit Care Med 2003; 168:1488-1494
15. Wilson DO, Rogers RM, Wright EC, et al. Body weight in chronic obstructive pulmonary disease: the National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am Rev Respir Dis 1989; 139:1435-1438
16. The Intermittent Positive Pressure Breathing Trial Group. Intermittent positive pressure breathing therapy of chronic obstructive pulmonary disease: a clinical trial. Ann Intern Med 1983; 99:612-620
17. Meyers BF, Yusen RD, Lefrak SS, et al. Outcome of Medicare patients with emphysema selected for, but denied, a lung volume reduction operation. Ann Thorac Surg 1998; 66:331-336
18. NETT Trialists. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003; 348:2059-2073
19. Russi EW, Stammberger U, Weder W. Lung volume reduction surgery for emphysema. Eur Respir J 1997; 10:208-218
20. ECCS working party. Standardization of lung function tests. Bull Eur Physiopatli Respir 1983; 19:7-92
21. American Thoracic Society. Surveillance for respiratory hazards in the occupational setting. Am Rev Respir Dis 1982; 126:952-956
22. Bernstein M, Despars JA, Singh NP, et al. Reanalysis of the 12-minute walk in patients with chronic obstructive pulmonary disease. Chest 1994; 105:163-167
23. McGavin CR, Gupta SP, McHardy GJR. Twelve-minute walking test for assessing disability in chronic bronchitis. BMJ 1976; 1:822-823
24. Butland RJA, Pang J, Gross ER, et al. Two-, six-, and 12-minute walking tests in respiratory disease. BMJ 1982; 284:1607-1608
25. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15:361-387
26. Cooper JD, Trulock EP, Triantafillou AN, et al. Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg 1995; 109:106-109
27. Ciccone AM, Meyers BF, Guthrie TJ, et al. Long-term outcome of bilateral lung volume reduction in 250 consecutive patients with emphysema. J Thorac Cardiovasc Surg 2003; 125:513-525
28. NETT Trialists. Patients at high risk of death after lung-volume- reduction surgery. N Engl J Med 2001; 345:1075-1083
29. Munro PE, Bailey MJ, Smith JA, et al. Lung volume reduction surgery in Australia and New Zealand: six years on; registry report. Chest 2003; 124:1443-1450
30. Gelb AF, McKenna RJ Jr, Brenner M, et al. Lung function 5 yr after lung volume reduction surgery for emphysema. Am J Respir Crit Care Med 2001; 163:1562-1566
31. Hosenpud JD, Bennett L, Keck BM, et al. Effect of diagnosis on survival benefit of lung transplantation for end- stage lung disease. Lancet 1998; 351:24-27